Vimarsana
Biggest News Aggregation in the World

Page 5 - Chembio Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chembio Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chembio Diagnostics Today - Breaking & Trending Today

Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com - Vimarsana News

Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock. Chembio Diagnostics Trading Up 0.2 % CEMI opened at $0.46 on Friday. Chembio Diagnostics has a 12-month low of […]

Equities Research Analysts' New Coverage for April 30th (AACG, AAME, AEY, AIRT, AKTX, ALIM, AP, APWC, ARTW, BBGI) - Vimarsana News

Equities Research Analysts' New Coverage for April 30th (AACG, AAME, AEY, AIRT, AKTX, ALIM, AP, APWC, ARTW, BBGI)

Equities Research Analysts’ new coverage for Sunday, April 30th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com assumed coverage on shares of Atlantic American (NASDAQ:AAME). They issued a hold rating on the stock. StockNews.com started coverage on shares of ADDvantage Technologies Group (NASDAQ:AEY). StockNews.com […]

Sale of test maker Chembio clears bar for shareholder approval on fourth try - Vimarsana News

Sale of test maker Chembio clears bar for shareholder approval on fourth try

The company, which has facilities in Medford and Bay Shore, manufactures rapid diagnostic tests for infectious diseases such as HIV, malaria, COVID-19 and Ebola.

Chembio Diagnostics (NASDAQ:CEMI) Receives New Coverage from Analysts at StockNews.com - Vimarsana News

Chembio Diagnostics (NASDAQ:CEMI) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the stock. Chembio Diagnostics Stock Performance Shares of NASDAQ CEMI opened at $0.46 on Friday. Chembio Diagnostics has a 52-week low of $0.19 and a 52-week high of $1.24. The […]

Chembio Diagnostics, Inc. (NASDAQ:CEMI) Short Interest Update - Vimarsana News

Chembio Diagnostics, Inc. (NASDAQ:CEMI) Short Interest Update

Chembio Diagnostics, Inc. (NASDAQ:CEMI – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 361,400 shares, a growth of 10.4% from the March 15th total of 327,400 shares. Based on an average daily trading volume, of 700,200 shares, […]